Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
300039.SZ Stock Price Chart
Explore Shanghai Kaibao Pharmaceutical CO.,Ltd interactive price chart. Choose custom timeframes to analyze 300039.SZ price movements and trends.
300039.SZ Company Profile
Discover essential business fundamentals and corporate details for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2010
Employees
1.33K
Website
https://www.xykb.comCEO
Yingbin Zhou
Description
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.
300039.SZ Financial Timeline
Browse a chronological timeline of Shanghai Kaibao Pharmaceutical CO.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 5 Jun 2025
EPS came in at ¥0.15 , while revenue for the quarter reached ¥352.08M .
Earnings released on 5 Jun 2025
Dividend declared on 29 May 2025
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 29 May 2025.
Earnings released on 31 Mar 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥400.64M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.07 , while revenue for the quarter reached ¥292.09M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.05 , while revenue for the quarter reached ¥348.43M .
Dividend declared on 19 Jun 2024
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 19 Jun 2024.
Earnings released on 5 Jun 2024
EPS came in at ¥0.13 , while revenue for the quarter reached ¥439.72M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.08 , while revenue for the quarter reached ¥475.50M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥307.98M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥386.96M .
Dividend declared on 26 May 2023
A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 26 May 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.08 , while revenue for the quarter reached ¥459.39M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥318.84M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥259.84M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥196.35M .
Dividend declared on 16 Jun 2022
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 16 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥343.82M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥305.63M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥256.91M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥198.13M .
Dividend declared on 9 Jun 2021
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 9 Jun 2021.
Earnings released on 23 Apr 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥260.22M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥339.91M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.03 , while revenue for the quarter reached ¥172.20M .
300039.SZ Stock Performance
Access detailed 300039.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.